Parkinson’s Disease / 2014 / Article / Tab 2

Clinical Study

Are Branded and Generic Extended-Release Ropinirole Formulations Equally Efficacious? A Rater-Blinded, Switch-Over, Multicenter Study

Table 2

Side-effect profile.

Requip (present/absent)Ralnea (present/absent)McNemar test ( value)

Orthostatic hypotension9/129/121.000
Daytime sleepiness18/319/21.000
Dizziness8/138/131.000
Confusion 0/212/190.500
Dyskinesia14/717/40.219
Hallucinations or pseudohallucinations4/173/181.000
Sexual disturbances1/202/191.000
Abdominal pain/discomfort2/197/140.125
Nausea1/203/180.500
Constipation7/146/151.000
Oedema13/810/110.250
Impulse control disorder0/210/211.000

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.